Fingerprint
Dive into the research topics of 'Inotuzumab ozogamicin in combination with low-intensity chemotherapy (mini-HCVD) with or without blinatumomab versus standard intensive chemotherapy (HCVAD) as frontline therapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically